Roberto Bei
Roberto Bei
Roberto Bei
Associate Professor of General Pathology
Department of Clinical Sciences and Translational Medicine
University of Rome "Tor Vergata"
Rome
Biography
Prof. Roberto Bei has received his MD and PhD in Experimental Medicine at the University of Rome “La Sapienza” during the period of 1983-1989 and 1993-1998, respectively. He is specialist in Medical Oncology and Clinical Pathology. Currently, he is working as Associate Professor in General Pathology at the University of Rome “Tor Vergata”. He has successfully completed his Administrative responsibilities as teacher and researcher at the University of Rome “Tor Vergata”. His research has included cancer immunotherapy and effect of natural compounds on cancer cell growth. Based on this research and fellowship training he has received several awards and honors, such as: Glaxo Wellcome Oncology Clinical Research Scholar 1998 and Award from Italian Society of Pathology and Oral Medicine AACR (1999). He is serving as an editorial member of several journals like The Open Pathology Journal (2009-2012), Recent Pat Inflamm Allergy Drug Discov (2009- today), Journal of Chinese Clinical Medicine (2010- today), Open J Immunology (2011-today), Open J Pathology (2011- today), Dataset Papers in Biology (2012-today), Journal of Life Medicine (2013-today), Pathology Discovery (2013-today) Frontiers in Pathogenic Biology (2013-today), American Journal of Current Immunology (Advisory 2013-today), Frontiers in Pharmaceutical Sciences (2013-today), Frontiers in Clinical Medicine (FCM) (2013-today) MOJ Immunology (2014-today, Senior Editor) , Journal of Immunology & Serum Biology (2015-today) Frontiers in Bioscience (Special issue: Tumor antigens: from spontaneous immune response in cancer patients to cancer vaccines) & expert Reviewers for journals like Journal of Immunology, Oral Oncology, The Open Pathology Journal, The Open Biomarkers Journal, International Journal of Gynecological Cancer, Human Immunology, Advances in Medical Sciences, Molecular Biology International, Redox Report, Int. J. Immunopathol. Pharmacol., Recent Pat Inflamm Allergy Drug Discov, Open J Immunology, Vaccine, Open Journal of Pathology, Oncotarget, Translational Research, Nutrients. He is the Principal Investigator of funded research grants. He has authored about 90 peer reviewed articles (Impact factor: 328, Science Citation Index edizione 2014). He is a member of AACR and Italian Pathology Society.
Research Interest
Analysis of immune response to tumor associated antigens (TAAs) (ErbB receptors, AFP, CEA, PSA) in cancer patients. Cancer immunotherapy: anti-cancer vaccines and murine and recombinant Mabs development Expression of TAAs in tumors and normal tissues. Production and characterization of monoclonal antibodies to viral proteins. Analysis of the effect of natural compounds on cancer cell growth. KEY WORDS: Cancer vaccines, tumor antigens, nutraceutical and cancer.
